US FDA widens investigation into cyclosporiasis cases to four more states
The U.S. Food and Drug Administration has expanded its investigation into an outbreak of cyclosporiasis, a parasitic intestinal illness, to include four additional states beyond those already under review.
Who should care: Lawyers · Privacy officers · Compliance